944280-14-2 Usage
Uses
Used in Organic Synthesis:
2-(4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-methylpropan-1-ol is used as a reagent for the formation of carbon-carbon and carbon-oxygen bonds in various chemical reactions. Its distinctive structure and functional groups enable the synthesis of complex organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-methylpropan-1-ol is utilized as a key intermediate in the development of new drugs. Its unique reactivity and stereochemical properties contribute to the design and synthesis of novel pharmaceutical compounds with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 944280-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,2,8 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 944280-14:
(8*9)+(7*4)+(6*4)+(5*2)+(4*8)+(3*0)+(2*1)+(1*4)=172
172 % 10 = 2
So 944280-14-2 is a valid CAS Registry Number.
944280-14-2Relevant academic research and scientific papers
CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
-
Page/Page column 44, (2008/06/13)
Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), A1 is a cyclic group, and B is a cyclic group which is attached to the heterocyclic ring directly or through a methylene group.
CETP INHIBITORS
-
Page/Page column 40, (2008/06/13)
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B.
